|
|
|
|
|
by perlgeek
6 days ago
|
|
The article is pretty light on details, but > Much like other CRISPR therapies, delivery is a critical challenge, i.e., getting the large genome-cutting enzyme to all the targeted cells efficiently. makes me think this is in vitro so far. So, years to decades away from being available for actual treatment in humans. Still good news. |
|